# Laurus Labs Ltd (LAURUSLABS)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹1404.7
Day Change: -2.91%
52W High: ₹1327.9
52W Low: ₹584.5
Market Cap: ₹70,884 Cr

## Valuation
P/E: 84.04
P/B: 14.75
EPS: ₹15.62
Book Value: ₹88.98
Dividend Yield: 0%

## Returns
1Y Return: 43.4%

## Profitability
ROE: 17.74%
ROCE: 9.77%
Debt/Equity: 0.46
Revenue Growth: 6%
Profit Growth: 19.4%
EBITDA Margin: 26.69%
Operating Margin: 22.04%

## About
Laurus Labs Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Laurus Labs Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication 13 May
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication 8 May
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication 13 May

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-06-08T20:00:07.519Z
Price History Updated: 2026-06-08T16:00:43.651Z
Latest Price History Date: 2026-06-08
Technicals Updated: 2026-06-08T16:00:43.651Z
Quant Updated: 2026-06-08T16:00:43.651Z
Sentiment Updated: 2026-06-08T16:00:43.651Z
Financials Status: current
Financials Updated: 2026-05-18T04:30:04.958Z
Financials Last Attempt: 2026-05-18T04:30:04.958Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2016)
Revenue: ₹1327 Cr
Operating Profit: ₹200 Cr (OPM 15%)
Net Profit: ₹68 Cr
Tax: ₹67 Cr

## Annual P&L History
Mar 2016: Rev ₹1327Cr | PAT ₹68Cr | OPM 15%
Mar 2017: Rev ₹1778Cr | PAT ₹134Cr | OPM 20%
Mar 2018: Rev ₹1905Cr | PAT ₹190Cr | OPM 21%

## Balance Sheet (Mar 2016)
Total Assets: ₹1888 Cr
Total Liabilities: ₹1888 Cr
Borrowings: ₹888 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Satyanarayana  Chava M.Sc., Ph.D., CEO & Whole Time Director
- Vantaram Venkata Ravi Kumar Dip in Mgmt., DIS, F.C.M.A., CFO & Whole-Time Director
- B. V. R. K. Suryadevara Srinivasa Rao, President of Manufacturing and Operations
- Gogireddy Venkateswar Reddy, VP of Legal, Compliance Officer & Company Secretary
- Narasimha Rao Chava, Executive Vice President of Human Resources

---
Source: rupiya.io/stocks/lauruslabs
Disclaimer: For research and education only. Not investment advice.